About ImmuneOncia Therapeutics Inc.
ImmuneOncia was established as a joint venture between Sorrento Therapeutics, USA and Yuhan Corporation, Korea, focusing on immuno-oncology and aims to bring safe, effective immunotherapies to patients worldwide.
State of Ownership
Business Development Executive, Nature Publishing Group
Sales Account Executive, Springer Nature